Apparent Triclabendazole-Resistant HumanFasciola hepaticaInfection, the Netherlands
Authors:
- Annemarie J.S. WinkelhagenAnnemarie J.S. Winkelhagen
- Theo MankTMTheo Mank
- Peter J. de VriesPVPeter J. de Vries
- Robin SoetekouwRSRobin Soetekouw
Open Access
- 1 June 2012
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 18 (6) , 1028-1029
Abstract
TO THE EDITOR: In December 2007, a 71-year-old sheep farmer sought care with a 4-month history of intermittent right upper quadrant pain, night sweats, anorexia, and a 5-kg weight loss. His medical history was unremarkable, and he had not traveled outside the Netherlands for ≈30 years. Physical examination revealed no abnormalitieKeywords
This publication has 8 references indexed in Scilit:
- Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazoleVeterinary Parasitology, 2012
- Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?Veterinary Parasitology, 2011
- Chapter 2 Fasciola, Lymnaeids and Human Fascioliasis, with a Global Overview on Disease Transmission, Epidemiology, Evolutionary Genetics, Molecular Epidemiology and Control2009
- Triclabendazole for the treatment of fascioliasis and paragonimiasisExpert Opinion on Investigational Drugs, 2005
- Lack of reversion in triclabendazoleresistant Fasciola hepaticaVeterinary Record, 2005
- An experimental study on triclabendazole resistance of Fasciola hepatica in sheepVeterinary Parasitology, 2001
- Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The NetherlandsVeterinary Parasitology, 2000
- [Fasciola hepatica infection; an unusual cause of severe anemia].1972